-
Meddenovo Drug Design
Created in 2021
-
-
Up & running (A)
Existing signals show a regular activity -
Social networks
1,278 -
Activities
-
Technologies
-
Entity types
-
Location
69100 Villeurbanne, France
Villeurbanne
France
-
Employees
Scale: 2-10
Estimated: 10
-
SIREN
980748040 -
Engaged catalyst
9
0 0 -
Added in Motherbase
2 years, 8 months ago
-
Value proposition
Meddenovo offers a unique blend of AI technologies and molecular modeling to design cyclic peptide therapeutics.
Meddenovo is advancing AI-driven drug discovery with a specialized technology platform designed specifically for cyclic peptides. Our platform can design cyclic peptides from scratch, even without prior experimental data, and incorporates cutting-edge technology to capture their chameleon-like properties, including cell permeability. This unique capability enables us to address previously undruggable targets with precision.
Cyclic peptides are a transformative class of compounds in pharmaceutical research, offering the advantages of both small molecules and large biologics, such as exceptional binding affinities, stability, and specificity. Technological advancements in the past decade have made peptides more accessible, and AI-driven companies like Meddenovo are now working to unlock their full potential to find cures for more diseases.
At Meddenovo, we are committed to precision and reliability in drug discovery. Our approach reduces failure rates and accelerates the journey from research to market, empowering scientists worldwide with advanced, user-friendly AI tools. By democratizing access to sophisticated drug discovery technologies, we enable a broader community to contribute to innovative treatments.
Discover how Meddenovo can transform your drug discovery process. With our advanced technologies and dedication to excellence, we are your partner in creating the next generation of medicines. Contact us today to learn more about custom access to our platform.
-
Meddenovo
http://meddenovo.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
Dell Technologies
Electricals, Computer Hardware Manufacturing (Auto) |
Dell Technologies
Electricals, Computer Hardware Manufacturing (Auto) |
Other
1 Aug 2026 |
|
|
CNRS
Research, Research Services (Auto) |
CNRS
Research, Research Services (Auto) |
Other
13 Mar 2026 |
|
|
Eurobiomed
Public business cluster, Biotechnology, French Cluster, Non-profit Organizations (Auto) |
Eurobiomed
Public business cluster, Biotechnology, French Cluster, Non-profit Organizations (Auto) |
Other
13 Mar 2026 |
|
|
Business France
National and local authorities, Government Administration (Auto) |
Business France
National and local authorities, Government Administration (Auto) |
Other
1 Jun 2026 |
|
|
Apec - Association Pour l'Emploi des Cadres
Human ressources, Human Resources (Auto) |
Apec - Association Pour l'Emploi des Cadres
Human ressources, Human Resources (Auto) |
Other
13 Mar 2026 |
|
|
Auvergne-Rhône-Alpes Entreprises
National and local authorities, Business Consulting and Services (Auto) |
Auvergne-Rhône-Alpes Entreprises
National and local authorities, Business Consulting and Services (Auto) |
Other
13 Feb 2025 |
|
|
HEC Paris
Higher Education (Auto) |
HEC Paris
Higher Education (Auto) |
Other
7 Aug 2024 |
|
|
Creative Valley
IT Services and IT Consulting (Auto) |
Creative Valley
IT Services and IT Consulting (Auto) |
Other
5 Jun 2024 |
|
|
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research (Auto) |
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research (Auto) |
Other
27 Jul 2026 |
|
|